Lixia Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Lixia Zhou has a total of 69 co-authors. Here are the top co-authors by number of shared publications:
Yimin Cao
Department of Medical Imaging, The Second Hospital of Hebei Medical University, No. 215 Heping West Street, Shijiazhuang, Hebei Province, 050000, China
8 shared publicationsDuo Gao
Department of Medical Imaging, The Second Hospital of Hebei Medical University, No. 215 Heping West Street, Shijiazhuang, Hebei Province, 050000, China
7 shared publicationsHaiqing Yang
Department of Medical Imaging, The Second Hospital of Hebei Medical University, No. 215 Heping West Street, Shijiazhuang, Hebei Province, 050000, China
6 shared publicationsZexi Yi
Department of Radiology The Second Hospital of Hebei Medical University Shijiazhuang Hebei China
6 shared publicationsXueying Zhao
Department of Radiology, The Second Hospital of Hebei Medical University, No. 215, Heping West Road, Xinhua District, Shijiazhuang City, 050000, Hebei Province, China
5 shared publicationsSicong Wang
GE Healthcare, Beijing, 100010, China
4 shared publications
Latest Publications
- 22 October 2026
- Published by Springer Nature in Neuroradiology
- p. 1-11
Imaging features of pituitary Crooke cell adenoma: a 13-case series
- 22 October 2026
- Published by Springer Nature in Neuroradiology
- p. 1-11
Imaging features of pituitary Crooke cell adenoma: a 13-case series
- Open Access
- 5 June 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (11) , 4372
Grade-Dependent Prognostic Value of Classical Clinicopathological Factors in Glioma: A Single-Center Retrospective Study
Background: The prognostic relevance of classical clinicopathological factors in glioma may vary across World Health Organization (WHO) grades. We examined whether anatomical location, Ki-67, and treatment-related variables show grade-dependent associations with survival. Methods: We retrospectively included 429 patients with glioma treated at a single center between 2012 and 2024. Patients were stratified into WHO grade 2–3 gliomas (n = 129) and WHO grade 4 gliomas (n = 300). Overall survival was evaluated using Kaplan–Meier analysis and Cox proportional hazards models. Additional exploratory analyses were performed in cases with known IDH status with adjustment for IDH and MGMT status. Results: Median overall survival for the full cohort was 29.93 months, and survival differed significantly across WHO grades. In grade 2–3 gliomas, higher Karnofsky Performance Status, non-deep location, and lower Ki-67 were associated with better survival; deep/midline location and Ki-67 ≥ 30% remained independently associated with worse overall survival. Within non-deep grade 2–3 tumors, temporal location was associated with worse survival. In grade 4 gliomas, female sex, non-deep location, and receipt of radiotherapy were independently associated with better survival, whereas Ki-67 was not prognostic. In exploratory molecularly adjusted analyses, deep/midline location remained associated with worse survival across grades, whereas the prognostic effect of Ki-67 became unstable. Longer chemotherapy duration showed a trend toward improved survival in grade 4 gliomas. Conclusions: Classical clinicopathological factors show substantial grade-dependent prognostic heterogeneity in glioma. Anatomical location appears to be a relatively stable adverse prognostic factor across grades, including after partial molecular adjustment. In contrast, the prognostic relevance of Ki-67 was less robust after adjustment for IDH and MGMT and should be interpreted cautiously as an exploratory, molecular-context-dependent marker.
- 5 June 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (11) , 4372
Open AccessGrade-Dependent Prognostic Value of Classical Clinicopathological Factors in Glioma: A Single-Center Retrospective Study
Background: The prognostic relevance of classical clinicopathological factors in glioma may vary across World Health Organization (WHO) grades. We examined whether anatomical location, Ki-67, and treatment-related variables show grade-dependent associations with survival. Methods: We retrospectively included 429 patients with glioma treated at a single center between 2012 and 2024. Patients were stratified into WHO grade 2–3 gliomas (n = 129) and WHO grade 4 gliomas (n = 300). Overall survival was evaluated using Kaplan–Meier analysis and Cox proportional hazards models. Additional exploratory analyses were performed in cases with known IDH status with adjustment for IDH and MGMT status. Results: Median overall survival for the full cohort was 29.93 months, and survival differed significantly across WHO grades. In grade 2–3 gliomas, higher Karnofsky Performance Status, non-deep location, and lower Ki-67 were associated with better survival; deep/midline location and Ki-67 ≥ 30% remained independently associated with worse overall survival. Within non-deep grade 2–3 tumors, temporal location was associated with worse survival. In grade 4 gliomas, female sex, non-deep location, and receipt of radiotherapy were independently associated with better survival, whereas Ki-67 was not prognostic. In exploratory molecularly adjusted analyses, deep/midline location remained associated with worse survival across grades, whereas the prognostic effect of Ki-67 became unstable. Longer chemotherapy duration showed a trend toward improved survival in grade 4 gliomas. Conclusions: Classical clinicopathological factors show substantial grade-dependent prognostic heterogeneity in glioma. Anatomical location appears to be a relatively stable adverse prognostic factor across grades, including after partial molecular adjustment. In contrast, the prognostic relevance of Ki-67 was less robust after adjustment for IDH and MGMT and should be interpreted cautiously as an exploratory, molecular-context-dependent marker.
- Open Access
- 20 May 2026
- Published by Springer Nature in BMC Medical Imaging
- Vol. 26 (1)
MRI features of fetal type I congenital choledochal cyst and parameter measurement of hepatobiliary development
To observe fetal MRI findings of type I congenital choledochal cyst (CCC) and the developmental differences in abdominal organs between fetuses with CCC and normal controls. This retrospective study included 90 normal fetuses and 31 fetuses with surgically confirmed CCC. MRI was used to observe CCC morphology, orientation, connection with bile duct or gallbladder, and its relationship with the liver edge. Cyst volume was calculated. Measurements, including the lung-to-liver signal intensity ratio (LLIR), liver (transverse and craniocaudal diameters, maximum cross-sectional area), spleen (long diameter, thickness, maximum cross-sectional area), gallbladder (long diameter, short diameter, maximum cross-sectional area), and portal vein diameter were compared between the two groups. Correlation between cyst volume and MRI parameters was analyzed. Among the 31 CCC cases, 70.9% were female. The choledochal cyst morphology was elliptical in 26 cases. A "pointed apex sign" was observed in all cases. The inferior margin of the cyst did not extend beyond the inferior edge of the liver in 29 cases. The predominant orientation of the cyst was right upper to left lower in 26 cases. Compared to controls, CCC fetuses showed significantly larger splenic cross-sectional area, increased portal vein diameter, and higher gallbladder long-to-short diameter ratio (all P < 0.05). CCC predominantly occurs in females. Fetal MRI findings typically show an elliptical lesion, generally not extending beyond the inferior edge of the liver, with a right upper to left lower orientation and a "pointed apex sign" at its superior margin. Affected fetuses exhibit an enlarged spleen, a widened portal vein, and an increased ratio of the gallbladder's long-to-short diameter. However, the cyst volume shows no correlation with these changes.
- 20 May 2026
- Published by Springer Nature in BMC Medical Imaging
- Vol. 26 (1)
Open AccessMRI features of fetal type I congenital choledochal cyst and parameter measurement of hepatobiliary development
To observe fetal MRI findings of type I congenital choledochal cyst (CCC) and the developmental differences in abdominal organs between fetuses with CCC and normal controls. This retrospective study included 90 normal fetuses and 31 fetuses with surgically confirmed CCC. MRI was used to observe CCC morphology, orientation, connection with bile duct or gallbladder, and its relationship with the liver edge. Cyst volume was calculated. Measurements, including the lung-to-liver signal intensity ratio (LLIR), liver (transverse and craniocaudal diameters, maximum cross-sectional area), spleen (long diameter, thickness, maximum cross-sectional area), gallbladder (long diameter, short diameter, maximum cross-sectional area), and portal vein diameter were compared between the two groups. Correlation between cyst volume and MRI parameters was analyzed. Among the 31 CCC cases, 70.9% were female. The choledochal cyst morphology was elliptical in 26 cases. A "pointed apex sign" was observed in all cases. The inferior margin of the cyst did not extend beyond the inferior edge of the liver in 29 cases. The predominant orientation of the cyst was right upper to left lower in 26 cases. Compared to controls, CCC fetuses showed significantly larger splenic cross-sectional area, increased portal vein diameter, and higher gallbladder long-to-short diameter ratio (all P < 0.05). CCC predominantly occurs in females. Fetal MRI findings typically show an elliptical lesion, generally not extending beyond the inferior edge of the liver, with a right upper to left lower orientation and a "pointed apex sign" at its superior margin. Affected fetuses exhibit an enlarged spleen, a widened portal vein, and an increased ratio of the gallbladder's long-to-short diameter. However, the cyst volume shows no correlation with these changes.
- Open Access
- 30 April 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1776880
MRI evaluation of ADC values and venous variations in fetal cerebral white matter with T2WI signal hyperintensity in late gestation
Background and purpose: We observed that some late-term fetal prenatal magnetic resonance imaging (MRI) scans revealed normal brain structures but exhibited diffuse hyperintense signals on T2-weighted imaging (T2WI) in the cerebral white matter (white matter hyperintense signal [WMHS]). Currently, the pathological basis of this phenomenon remains unclear, and few studies have systematically investigated its impact on fetal and postnatal brain development. We aimed to compare the differences in apparent diffusion coefficient (ADC) values across distinct brain regions between fetuses with WMHS and age-matched control fetuses, to explore the potential etiology of WMHS by combining these findings with morphological changes in cerebral veins, and to conduct a comprehensive evaluation combined with clinical follow-up. Method: We retrospectively analyzed fetal imaging data from MRI examinations performed at our hospital between January 2014 and May 2024. A total of 87 late-term fetuses (gestational age [GA]: 29–40 weeks) were identified with diffuse hyperintense signals on T2WI in the cerebral parenchyma; age-matched normal fetuses with the same sample size were enrolled as the control group. We compared differences in ADC values across distinct brain regions among fetuses with WMHS and simultaneously analyzed morphological differences in the deep cerebral veins between the two groups, combined with postnatal clinical follow-up, to explore the impact of WMHS on brain development and its clinical significance in late-term fetuses. Results: (1) ADC values in the majority of brain regions of fetuses in the WMHS group were higher than those in the control group, with the greatest difference observed in the F2 region. (2) Compared with the control group, fetuses in the WMHS group exhibited significantly increased lumen areas of the vein of Galen (VOG) and straight sinus (SS), with a p -value of < 0.05 considered statistically significant. (3) Successful follow-up was achieved in 45 control infants and 36 WMHS cases. All control fetuses showed normal neurodevelopmental outcomes, while 33 infants in the WMHS group had normal and 3 had adverse outcomes, including cerebral palsy, developmental delay, and autism. Conclusion: In late-term fetuses with WMHS, elevated ADC values in specific brain regions and concurrent deep cerebral venous dilation indicate underlying intracranial abnormalities. In addition, our follow-up results indicate that these combined changes may be associated with adverse neurodevelopmental outcomes in some infants.
- 30 April 2026
- Published by Frontiers Media SA in Frontiers in Medicine
- Vol. 13, 1776880
Open AccessMRI evaluation of ADC values and venous variations in fetal cerebral white matter with T2WI signal hyperintensity in late gestation
Background and purpose: We observed that some late-term fetal prenatal magnetic resonance imaging (MRI) scans revealed normal brain structures but exhibited diffuse hyperintense signals on T2-weighted imaging (T2WI) in the cerebral white matter (white matter hyperintense signal [WMHS]). Currently, the pathological basis of this phenomenon remains unclear, and few studies have systematically investigated its impact on fetal and postnatal brain development. We aimed to compare the differences in apparent diffusion coefficient (ADC) values across distinct brain regions between fetuses with WMHS and age-matched control fetuses, to explore the potential etiology of WMHS by combining these findings with morphological changes in cerebral veins, and to conduct a comprehensive evaluation combined with clinical follow-up. Method: We retrospectively analyzed fetal imaging data from MRI examinations performed at our hospital between January 2014 and May 2024. A total of 87 late-term fetuses (gestational age [GA]: 29–40 weeks) were identified with diffuse hyperintense signals on T2WI in the cerebral parenchyma; age-matched normal fetuses with the same sample size were enrolled as the control group. We compared differences in ADC values across distinct brain regions among fetuses with WMHS and simultaneously analyzed morphological differences in the deep cerebral veins between the two groups, combined with postnatal clinical follow-up, to explore the impact of WMHS on brain development and its clinical significance in late-term fetuses. Results: (1) ADC values in the majority of brain regions of fetuses in the WMHS group were higher than those in the control group, with the greatest difference observed in the F2 region. (2) Compared with the control group, fetuses in the WMHS group exhibited significantly increased lumen areas of the vein of Galen (VOG) and straight sinus (SS), with a p -value of < 0.05 considered statistically significant. (3) Successful follow-up was achieved in 45 control infants and 36 WMHS cases. All control fetuses showed normal neurodevelopmental outcomes, while 33 infants in the WMHS group had normal and 3 had adverse outcomes, including cerebral palsy, developmental delay, and autism. Conclusion: In late-term fetuses with WMHS, elevated ADC values in specific brain regions and concurrent deep cerebral venous dilation indicate underlying intracranial abnormalities. In addition, our follow-up results indicate that these combined changes may be associated with adverse neurodevelopmental outcomes in some infants.
- Open Access
- 30 April 2026
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 14, 1857727
Correction: Prenatal diagnosis of midgut volvulus by fetal MRI: a retrospective study
- 30 April 2026
- Published by Frontiers Media SA in Frontiers in Pediatrics
- Vol. 14, 1857727
Open AccessCorrection: Prenatal diagnosis of midgut volvulus by fetal MRI: a retrospective study
- 14 April 2026
- Published by Springer Nature in Child's Nervous System
- Vol. 42 (1)
A case report about extracranial skeletal metastases in pediatric diffuse midline glioma, H3 K27-altered
We report a rare case of diffuse midline glioma, H3K27-altered (DMG), with extracranial metastases in a 9-year-old boy. The patient, initially treated with standard chemoradiotherapy, developed radiographically confirmed vertebral and peritoneal metastases within several months. Despite aggressive therapy, survival was short, underscoring the dismal prognosis associated with extraneural dissemination in DMG. Characteristic imaging findings and potential mechanisms of metastasis are discussed. This case highlights the need for early recognition and comprehensive systemic evaluation in managing atypical metastatic patterns of DMG.
- 14 April 2026
- Published by Springer Nature in Child's Nervous System
- Vol. 42 (1)
A case report about extracranial skeletal metastases in pediatric diffuse midline glioma, H3 K27-altered
We report a rare case of diffuse midline glioma, H3K27-altered (DMG), with extracranial metastases in a 9-year-old boy. The patient, initially treated with standard chemoradiotherapy, developed radiographically confirmed vertebral and peritoneal metastases within several months. Despite aggressive therapy, survival was short, underscoring the dismal prognosis associated with extraneural dissemination in DMG. Characteristic imaging findings and potential mechanisms of metastasis are discussed. This case highlights the need for early recognition and comprehensive systemic evaluation in managing atypical metastatic patterns of DMG.
- 4 October 2025
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 63 (2) , 596-606
Association of Blood–Brain Barrier Function With Disease Activity and Cognitive Function in Systemic Lupus Erythematosus Patients
Background: Disruption of the blood–brain barrier ( BBB ) is an important mechanism in the pathogenesis of neuropsychiatric systemic lupus erythematosus ( NPSLE ), potentially influencing disease progression and cognitive function. Purpose: To investigate voxel‐wise BBB permeability differences among NPSLE , non‐ NPSLE , and healthy controls ( HC ) using dynamic contrast‐enhanced MRI ( DCE ‐ MRI ), and explore associations with disease activity and cognitive function. Study Type: Multicenter, cross‐sectional study. Subjects: 22 NPSLE patients, 24 non‐NPSLE patients, and 27 age‐ and sex‐matched HC. Field Strength/Sequence: 3.0 Tesla, GE: 3D T1‐FSPGR, DCE‐LAVA‐Flex sequences; Philips: 3D T1‐FFE, eTHRIVE sequences. Assessment: Post‐processing of DCE‐MRI images was conducted to calculate the volume transfer constant (K trans ) and plasma volume fraction (V p ) maps, which were transformed to Montreal Neurological Institute space. Brain regions were defined using the Anatomical Automatic Labeling (AAL) atlas. Group differences among NPSLE, non‐NPSLE, and HC were assessed. Mean K trans /V p values from suprathreshold clusters were evaluated for associations with the Disease Activity Index (SLEDAI) and Montreal Cognitive Assessment (MoCA) scores. Mean K trans /V p from corresponding AAL regions was extracted for further validation of the observed correlations. Statistical Tests: Voxel‐wise ANOVA with Tukey's HSD test; Spearman correlation and linear regression. Threshold: Voxel‐wise p < 0.001, cluster size > 20; group comparisons p < 0.05. Results: A significantly elevated K trans was observed in the right caudate of NPSLE patients compared to non‐ NPSLE patients, and hippocampal K trans was significantly higher in NPSLE than both non‐ NPSLE and HC . Both NPSLE and non‐ NPSLE patients exhibited widespread significant increases in V p compared to HC . In the entire SLE cohort, right caudate K trans was positively associated with SLEDAI ( ρ = 0.43, R 2 = 0.18) and negatively associated with MoCA scores ( ρ = −0.35, R 2 = 0.12) after adjusting for confounding factors. Data Conclusion: This study provided voxel‐level evidence linking regional BBB leakage to both disease activity and cognitive impairment in SLE. Evidence Level: 2. Technical Efficacy: Stage 2.
- 4 October 2025
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 63 (2) , 596-606
Association of Blood–Brain Barrier Function With Disease Activity and Cognitive Function in Systemic Lupus Erythematosus Patients
Background: Disruption of the blood–brain barrier ( BBB ) is an important mechanism in the pathogenesis of neuropsychiatric systemic lupus erythematosus ( NPSLE ), potentially influencing disease progression and cognitive function. Purpose: To investigate voxel‐wise BBB permeability differences among NPSLE , non‐ NPSLE , and healthy controls ( HC ) using dynamic contrast‐enhanced MRI ( DCE ‐ MRI ), and explore associations with disease activity and cognitive function. Study Type: Multicenter, cross‐sectional study. Subjects: 22 NPSLE patients, 24 non‐NPSLE patients, and 27 age‐ and sex‐matched HC. Field Strength/Sequence: 3.0 Tesla, GE: 3D T1‐FSPGR, DCE‐LAVA‐Flex sequences; Philips: 3D T1‐FFE, eTHRIVE sequences. Assessment: Post‐processing of DCE‐MRI images was conducted to calculate the volume transfer constant (K trans ) and plasma volume fraction (V p ) maps, which were transformed to Montreal Neurological Institute space. Brain regions were defined using the Anatomical Automatic Labeling (AAL) atlas. Group differences among NPSLE, non‐NPSLE, and HC were assessed. Mean K trans /V p values from suprathreshold clusters were evaluated for associations with the Disease Activity Index (SLEDAI) and Montreal Cognitive Assessment (MoCA) scores. Mean K trans /V p from corresponding AAL regions was extracted for further validation of the observed correlations. Statistical Tests: Voxel‐wise ANOVA with Tukey's HSD test; Spearman correlation and linear regression. Threshold: Voxel‐wise p < 0.001, cluster size > 20; group comparisons p < 0.05. Results: A significantly elevated K trans was observed in the right caudate of NPSLE patients compared to non‐ NPSLE patients, and hippocampal K trans was significantly higher in NPSLE than both non‐ NPSLE and HC . Both NPSLE and non‐ NPSLE patients exhibited widespread significant increases in V p compared to HC . In the entire SLE cohort, right caudate K trans was positively associated with SLEDAI ( ρ = 0.43, R 2 = 0.18) and negatively associated with MoCA scores ( ρ = −0.35, R 2 = 0.12) after adjusting for confounding factors. Data Conclusion: This study provided voxel‐level evidence linking regional BBB leakage to both disease activity and cognitive impairment in SLE. Evidence Level: 2. Technical Efficacy: Stage 2.
- Open Access
- 4 July 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1613142
Chronic central nervous system aspergillosis with coexisting GFAP and AQP4 antibody positivity: case report and literature review
This article presents an unusual case of chronic central nervous system (CNS) aspergillosis with concurrent glial fibrillary acidic protein (GFAP)-IgG and aquaporin-4 (AQP4)-IgG seropositivity. The patient presented with progressive numbness and weakness of the extremities over three months. The diagnosis was established by a cell-based assay demonstrating double positivity for GFAP-IgG and AQP4-IgG; imaging revealed multiple foci in the right temporo-occipital lobe and cervical medulla. Surgical pathology confirmed parenchymal Aspergillus infection. Postoperative treatment with voriconazole was effective. This case represents, to our knowledge, the first report of chronic CNS aspergillosis with concurrent GFAP-IgG and AQP4-IgG positivity. These findings suggest that chronic fungal infections may induce multiple distinct antibody responses, thereby offering new insights into the mechanisms linking infection and immunity. Clinical vigilance is therefore warranted for the development of autoimmune antibodies following chronic fungal infections, and an early diagnosis may be facilitated by integrating clinical, imaging, and pathological evaluations.
- 4 July 2025
- Published by Frontiers Media SA in Frontiers in Immunology
- Vol. 16, 1613142
Open AccessChronic central nervous system aspergillosis with coexisting GFAP and AQP4 antibody positivity: case report and literature review
This article presents an unusual case of chronic central nervous system (CNS) aspergillosis with concurrent glial fibrillary acidic protein (GFAP)-IgG and aquaporin-4 (AQP4)-IgG seropositivity. The patient presented with progressive numbness and weakness of the extremities over three months. The diagnosis was established by a cell-based assay demonstrating double positivity for GFAP-IgG and AQP4-IgG; imaging revealed multiple foci in the right temporo-occipital lobe and cervical medulla. Surgical pathology confirmed parenchymal Aspergillus infection. Postoperative treatment with voriconazole was effective. This case represents, to our knowledge, the first report of chronic CNS aspergillosis with concurrent GFAP-IgG and AQP4-IgG positivity. These findings suggest that chronic fungal infections may induce multiple distinct antibody responses, thereby offering new insights into the mechanisms linking infection and immunity. Clinical vigilance is therefore warranted for the development of autoimmune antibodies following chronic fungal infections, and an early diagnosis may be facilitated by integrating clinical, imaging, and pathological evaluations.
- 2 June 2025
- Published by Springer Nature in Child's Nervous System
- Vol. 41 (1) , 1-12
Advancements in MRI application in the morphological development of fetal cerebral venous system: a review
The cerebral venous system plays a critical role in fetal brain development. Accurate assessment of the structure and function of the cerebral venous system is essential for early diagnosing fetal conditions related to cerebral venous system abnormalities and monitoring the brain health of fetuses in high-risk pregnancies. It provides reliable prenatal counseling to parents, enabling them to make informed prenatal choices. However, there is a lack of research on the fetal cerebral venous system, making its developmental process poorly understood. In recent years, the application of magnetic resonance imaging (MRI) has become increasingly mature in the field of fetal cranial and brain disorders due to its non-invasive characteristics and high sensitivity. The examination sequences are constantly being updated, playing an increasingly important role in the evaluation of the fetal cerebral venous system. This article presents the application value of MRI in the diagnosis of common fetal cerebral venous system abnormalities. It specifically reviews the application of conventional prenatal MRI, susceptibility weighted imaging (SWI), and quantitative susceptibility mapping (QSM) in the assessment of the structure and function of the fetal cerebral venous system. Additionally, the article provides an overview of the prospects and potential future directions in this field.
- 2 June 2025
- Published by Springer Nature in Child's Nervous System
- Vol. 41 (1) , 1-12
Advancements in MRI application in the morphological development of fetal cerebral venous system: a review
The cerebral venous system plays a critical role in fetal brain development. Accurate assessment of the structure and function of the cerebral venous system is essential for early diagnosing fetal conditions related to cerebral venous system abnormalities and monitoring the brain health of fetuses in high-risk pregnancies. It provides reliable prenatal counseling to parents, enabling them to make informed prenatal choices. However, there is a lack of research on the fetal cerebral venous system, making its developmental process poorly understood. In recent years, the application of magnetic resonance imaging (MRI) has become increasingly mature in the field of fetal cranial and brain disorders due to its non-invasive characteristics and high sensitivity. The examination sequences are constantly being updated, playing an increasingly important role in the evaluation of the fetal cerebral venous system. This article presents the application value of MRI in the diagnosis of common fetal cerebral venous system abnormalities. It specifically reviews the application of conventional prenatal MRI, susceptibility weighted imaging (SWI), and quantitative susceptibility mapping (QSM) in the assessment of the structure and function of the fetal cerebral venous system. Additionally, the article provides an overview of the prospects and potential future directions in this field.
- 7 March 2025
- Published by Elsevier in European Journal of Radiology
- Vol. 186, 112037
Intracranial vessel wall enhancement scoring system for monitoring disease activity and neuropsychiatric impairment in systemic lupus erythematosus
- 7 March 2025
- Published by Elsevier in European Journal of Radiology
- Vol. 186, 112037
Intracranial vessel wall enhancement scoring system for monitoring disease activity and neuropsychiatric impairment in systemic lupus erythematosus